glp 1 death rate Primary endpoint 30-day mortality by GLP-1 levels above the median at GLP-1 receptor agonists show promise
Description
The success of weight loss medications varies from person to person

We just dont know about the breast cancer recurrence risk, and yet there are no negative signals

However, for the vast majority of patients taking these medications for diabetes or weight management, this reduction in fluid intake represents a significant health challenge rather than a benefit

Recent studies have indicated that GLP-1RAs may possess neuroprotective properties (12) and directly reduce ICP

J Am Coll Cardiol, 2018

Oral GLP-1 uses
